These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13693869)

  • 1. Inhibition of DOPA decarboxylase in vitro and in vivo.
    CLARK WG; POGRUND RS
    Circ Res; 1961 May; 9():721-33. PubMed ID: 13693869
    [No Abstract]   [Full Text] [Related]  

  • 2. DOPA decarboxylase inhibition through the interaction of coenzyme and substrate.
    SCHOTT HF; CLARK WG
    J Biol Chem; 1952 May; 196(1):449-62. PubMed ID: 12980987
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nerve tissue DOPA decarboxylase and histidine decarboxylase].
    HOLTZ P; WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 227(6):538-46. PubMed ID: 13334561
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the inhibition of L-glutamic acid and L-DOPA decarboxylase by D-cycloserine and other isoxazolidones].
    DENGLER HJ; RAUCHS E; RUMMEL W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1962; 243():366-81. PubMed ID: 13885421
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro reversal of glutamate decarboxylase inhibition induced by 1,1-dimethylhydrazine.
    MEDINA MA; BRAYMER HD; REEVES JL
    J Neurochem; 1962; 9():307-12. PubMed ID: 14472005
    [No Abstract]   [Full Text] [Related]  

  • 6. Decarboxylase inhibitors in the treatment of hypertension.
    BREST AN; MOYER JH
    Am J Cardiol; 1962 Jan; 9():116-9. PubMed ID: 13872878
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the purification and specificity of DOPA-decarboxylase].
    WERLE E; AURES D
    Hoppe Seylers Z Physiol Chem; 1959 Sep; 316():45-60. PubMed ID: 13844020
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia.
    FELLMAN JH
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):413-4. PubMed ID: 13389476
    [No Abstract]   [Full Text] [Related]  

  • 9. [On purification and specificity of DOPA decarboxylase].
    WERLE E; AURES D
    Psychiatr Neurol (Basel); 1960 Jul; 140():227-36. PubMed ID: 13784426
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of DOPA decarboxylase by pyridoxal phosphate.
    AWAPARA J; SANDMAN RP; HANLY C
    Arch Biochem Biophys; 1962 Sep; 98():520-5. PubMed ID: 13863437
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of thyroxin and triiodothyronine on the activity of amine oxydase and DOPA decarboxylase in liver].
    WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):159-60. PubMed ID: 13334595
    [No Abstract]   [Full Text] [Related]  

  • 12. Competitive inhibition of 3, 4-dihydroxyphenylalanine (DOPA) decarboxylase in vitro.
    HARTMAN WJ; AKAWIE RI; CLARK WG
    J Biol Chem; 1955 Oct; 216(2):507-29. PubMed ID: 13271331
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of thyroxin and starvation on the activity of amine oxidase and DOPA-decarboxylase in liver].
    HOLTZ P; STOCK K; WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(3):322-30. PubMed ID: 13334654
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on inhibition of L-DOPA decarboxylase in vitro and in vivo.
    CLARK WG
    Pharmacol Rev; 1959 Jun; 11(2, Part 2):330-49. PubMed ID: 13667413
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological antagonism between pyridoxal 5-phosphate (activator of DOPA decarboxylase) and certain hydrazines (inhibitors of monoamine oxidase)].
    LEVY J; MICHEL-BER E
    C R Hebd Seances Acad Sci; 1960 Jun; 250():4061-3. PubMed ID: 14416402
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of DOPA decarboxylase by alpha-methyl-DOPA in vivo].
    REICHEL G; DENGLER H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 234(4):275-81. PubMed ID: 13600395
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of orotidylic acid decarboxylase, a primary site of carcinostasis by 6-azauracil.
    HANDSCHUMACHER RE; PASTERNAK CA
    Biochim Biophys Acta; 1958 Nov; 30(2):451-2. PubMed ID: 13607480
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of brain glutamic decarboxylase by running fit-inducing substances.
    NISHIZAWA Y; KODAMA T; YAMANAKA T
    J Vitaminol (Kyoto); 1959 Jun; 5():111-6. PubMed ID: 14427322
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of aspartic omega-decarboxylase by iso-nicotinic hydrazide].
    CATTANEO-LACOMBE J; SENEZ JC
    C R Seances Soc Biol Fil; 1956 Sep; 150(4):748-50. PubMed ID: 13365199
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of histidine decarboxylases.
    ROBINSON B; SHEPHERD DM
    Biochim Biophys Acta; 1961 Oct; 53():431-3. PubMed ID: 14492884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.